share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Tony

SEC ·  Mar 28 06:10
Summary by Futu AI
Tony Goodman, the Chief Operating Officer of Adial Pharmaceuticals, Inc. (ADIL), was reported to have engaged in a transaction involving the company's stock on March 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The number of shares held by Goodman after the transaction was also not provided. This information is crucial for investors to understand the insider activity within Adial Pharmaceuticals and may influence their investment decisions.
Tony Goodman, the Chief Operating Officer of Adial Pharmaceuticals, Inc. (ADIL), was reported to have engaged in a transaction involving the company's stock on March 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The number of shares held by Goodman after the transaction was also not provided. This information is crucial for investors to understand the insider activity within Adial Pharmaceuticals and may influence their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.